Liuqing Wei

3.4k total citations
36 papers, 774 citations indexed

About

Liuqing Wei is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Liuqing Wei has authored 36 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Organic Chemistry and 5 papers in Cancer Research. Recurrent topics in Liuqing Wei's work include Protease and Inhibitor Mechanisms (5 papers), Chemical Synthesis and Analysis (4 papers) and Synthesis and Catalytic Reactions (3 papers). Liuqing Wei is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Chemical Synthesis and Analysis (4 papers) and Synthesis and Catalytic Reactions (3 papers). Liuqing Wei collaborates with scholars based in United States, China and Russia. Liuqing Wei's co-authors include Allyn T. Londregan, Sandra M. Jennings, Gary E. Aspnes, Nathan E. Genung, David W. Piotrowski, Jun Xiao, Thomas A. Brandt, Anne‐Marie Dechert‐Schmitt, Adam S. Kamlet and Kevin R. Alliston and has published in prestigious journals such as Journal of the American Chemical Society, The Science of The Total Environment and Chemical Engineering Journal.

In The Last Decade

Liuqing Wei

34 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liuqing Wei United States 12 485 258 82 52 52 36 774
Yikai Wang China 17 558 1.2× 388 1.5× 50 0.6× 46 0.9× 103 2.0× 39 904
Frederick W. Goldberg United Kingdom 15 418 0.9× 320 1.2× 38 0.5× 17 0.3× 53 1.0× 35 807
Daniel R. Goldberg United States 13 439 0.9× 259 1.0× 51 0.6× 19 0.4× 17 0.3× 16 677
Abhishek Sharma United States 18 686 1.4× 225 0.9× 56 0.7× 16 0.3× 48 0.9× 45 936
Stephen E. de Laszlo United States 16 482 1.0× 394 1.5× 35 0.4× 38 0.7× 33 0.6× 28 786
Sven Ruf Germany 15 220 0.5× 393 1.5× 63 0.8× 37 0.7× 50 1.0× 31 741
Cinzia Aiello Italy 16 376 0.8× 306 1.2× 41 0.5× 21 0.4× 43 0.8× 29 800
Mi Yan China 12 393 0.8× 296 1.1× 33 0.4× 14 0.3× 61 1.2× 21 866
Guolin Zhang China 19 593 1.2× 247 1.0× 41 0.5× 20 0.4× 67 1.3× 61 950
Sarbjit Singh United States 14 369 0.8× 161 0.6× 72 0.9× 16 0.3× 35 0.7× 38 608

Countries citing papers authored by Liuqing Wei

Since Specialization
Citations

This map shows the geographic impact of Liuqing Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liuqing Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liuqing Wei more than expected).

Fields of papers citing papers by Liuqing Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liuqing Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liuqing Wei. The network helps show where Liuqing Wei may publish in the future.

Co-authorship network of co-authors of Liuqing Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Liuqing Wei. A scholar is included among the top collaborators of Liuqing Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liuqing Wei. Liuqing Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Jiaxin, Bingyang Wang, Liuqing Wei, et al.. (2025). Spherical nanoparticle-stabilized perilla aldehyde picolin emulsion functionalized polyvinyl alcohol/gelatin composite film for strawberry preservation. Chemical Engineering Journal. 511. 161638–161638. 9 indexed citations
3.
English, Alexander Scott, et al.. (2023). Rice‐farming areas report more anxiety across two years of the COVID‐19 pandemic in China. Social and Personality Psychology Compass. 17(9). 6 indexed citations
4.
Aspnes, Gary E., Steven B. Coffey, Anne‐Marie Dechert‐Schmitt, et al.. (2023). Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups. Bioorganic & Medicinal Chemistry Letters. 92. 129394–129394. 1 indexed citations
5.
Aspnes, Gary E., Scott W. Bagley, Steven B. Coffey, et al.. (2023). 6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor. Bioorganic & Medicinal Chemistry Letters. 94. 129454–129454. 4 indexed citations
6.
Baldwin, Aaron F., Shawn Cabral, Jeffrey T. Kohrt, et al.. (2023). Route Optimization of the Non-covalent Modulator of Hemoglobin PF-07059013 for the Treatment of Sickle Cell Disease, Part I: From Discovery Synthesis to First Kilogram-Scale Manufacture. Organic Process Research & Development. 27(5). 854–865. 2 indexed citations
7.
Wei, Liuqing, et al.. (2023). An fMRI study of visual geometric shapes processing. Frontiers in Neuroscience. 17. 1087488–1087488. 5 indexed citations
8.
Wei, Liuqing, et al.. (2023). A plasma proteomic approach in patients with heart failure after acute myocardial infarction: insights into the pathogenesis and progression of the disease. Frontiers in Cardiovascular Medicine. 10. 1153625–1153625. 4 indexed citations
11.
Liu, Jia, Liuqing Wei, Dan Zhang, et al.. (2022). The effects of inorganic anions on degradation kinetics and isotope fractionation during the transformation of tris(2-chloroethyl) phosphate (TCEP) by UV/persulfate. The Science of The Total Environment. 846. 157462–157462. 14 indexed citations
12.
Lu, Ting, Xinyu Zhang, Zhihong Ren, et al.. (2021). Effects of Wise Intervention on Perceived Discrimination Among College Students Returning Home From Wuhan During the COVID-19 Outbreak. Frontiers in Psychology. 12. 689251–689251. 2 indexed citations
13.
Londregan, Allyn T., Gary E. Aspnes, Chris Limberakis, et al.. (2018). Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3685–3688. 10 indexed citations
14.
Lintner, Nathanael G., Kim F. McClure, Donna N. Petersen, et al.. (2017). Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain. PLoS Biology. 15(3). e2001882–e2001882. 94 indexed citations
15.
Dou, Dengfeng, et al.. (2010). Inhibitors of human neutrophil elastase based on a highly functionalized N-amino-4-imidazolidinone scaffold. European Journal of Medicinal Chemistry. 45(9). 4280–4287. 7 indexed citations
16.
Dou, Dengfeng, Yi Li, Zhong Lai, et al.. (2009). Utilization of the 1,2,3,5-thiatriazolidin-3-one 1,1-dioxide scaffold in the design of potential inhibitors of human neutrophil proteinase 3. Bioorganic & Medicinal Chemistry. 18(3). 1093–1102. 17 indexed citations
17.
Lippa, Blaise, Gonghua Pan, Matthew S. Corbett, et al.. (2008). Synthesis and structure based optimization of novel Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3359–3363. 64 indexed citations
18.
Wei, Liuqing, Zhong Lai, Kevin R. Alliston, et al.. (2004). Mechanism-based inactivation of human leukocyte elastase via an enzyme-induced sulfonamide fragmentation process. Archives of Biochemistry and Biophysics. 429(1). 60–70. 5 indexed citations
19.
Lai, Zhong, et al.. (2004). Potent inhibition of human leukocyte elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamide derivatives. Archives of Biochemistry and Biophysics. 429(2). 191–197. 17 indexed citations
20.
Wei, Liuqing, et al.. (2003). Noncovalent inhibitors of human leukocyte elastase based on the 4-imidazolidinone scaffold. Bioorganic & Medicinal Chemistry. 11(23). 5149–5153. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026